CMS requires providers to confirm the medication is used for weight reduction along with ongoing lifestyle changes, and that the individual met one of the following when treatment started: BMI 35 BMI 30 with conditions like HFpEF, uncontrolled hypertension, or CKD (stage 3a+) BMI 27 with prediabetes or established cardiovascular disease (e.g., prior MI, stroke, PAD) One important note: this coverage will operate outside of typical Part D plans, so the approval process will look different
Semaglutide is FDA-approved for specific indications, including type 2 diabetes and chronic weight management under approved labeling
Most patients choose the 12-week plan for its balance of cost and effectiveness
Combined with healthy habits and lifestyle changes, semaglutide helps patients manage their weight
Magnesium plays a critical role in cardiovascular health
Recent studies suggest it may improve cardiovascular health and provide anti-cancer benefits, making it a comprehensive tool for overall longevity